 adjuvant cancer chemotherapy development of a dosage schedule for adjuvant cancer chemotherapy in surgical cases an account is given of the development of a dosage schedule for adjuvant cancer chemotherapy for surgical patients. this treatment was administered for two purposes: as an adjuvant to radical surgery to reduce the risk of blood-borne metastases. as a palliative measure for non-radically operated and inoperable patients. for these purposes 3 dosage levels were fixed: a maximum tolerated dose for adjuvant therapy. a maximum tolerated dose for parenteral palliative therapy. a maximum tolerated dose for oral palliative therapy. for this treatment the authors used 2 antimitotics, sp-i and sp-g, both of which are podophyllin derivatives. 